“…There is increasing evidence for the role of peripheral mechanisms in
chronic pain syndromes (e.g., Parada et al, 2003;
Christoph et al, 2005; Villarreal et al, 2005; Staud,
2010; Ferrari et al, 2014; Ma and Quirion, 2014; Yang et al, 2014; Boada et al, 2015), and
some of the most well-established peripheral changes are up-regulation of the NMDA subtype
of glutamate receptors (Du et al, 2003; Jang et al, 2004; Childers and Baudy, 2007), and of voltage sensitive sodium channels (Wang et al, 2002; Black
et al, 2004; Coggeshall et al, 2004; Lai et al, 2004; Dib-Hajj et al, 2007; Levinson et al,
2012). Such neuroadaptive events provide candidate targets for development of
multi-target medications for treatment of chronic pain.…”